AORT Artivion

• None no insider bought on the open market
• $7.2M sold by 7 insiders outside a trading plan
• $4.9M sold by 4 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Andrew M Green SVP, Regulatory and Quality
   Sale
   $287K 11,480 shares at $24.97 22% of stake
   Traded Sep 10 Filed Sep 11
   ↗
3. Andrew M Green SVP, Regulatory and Quality
   Sale
   $216K 8,003 shares at $27.03 13% of stake
   Traded Sep 2–3 Filed Sep 4
   ↗
4. James P Mackin CEO
   Sale
   $2M 70,000 shares at $28.96 7.4% of stake
   Traded Aug 19 Filed Aug 20
   ↗
5. Jean F Holloway SVP, General Counsel
   Sale
   $28K 977 shares at $28.49 0.5% of stake
   Traded Aug 12 Filed Aug 12
   ↗
6. Andrew M Green SVP, Regulatory and Quality
   Planned sale
   $911K 44,001 shares at $20.70 42% of stake
   Traded Jun 11 Filed Jun 15
   ↗
7. Jean F Holloway SVP, General Counsel
   Sale
   $341K 8,962 shares at $38.00 4.6% of stake
   Traded Mar 4 Filed Mar 4
   ↗
8. John E Davis Chief Commercial Officer
   Sale
   $226K 5,000 shares at $45.11 2.5% of stake
   Traded Dec 15, 2025 Filed Dec 17, 2025
   ↗
9. James P Mackin CEO
   Planned sale
   $1.4M 30,921 shares at $45.46 3.7% of stake
   Traded Dec 3, 2025 Filed Dec 4, 2025
   ↗
10. Jean F Holloway SVP, General Counsel
    Sale
    $331K 7,315 shares at $45.30 4.5% of stake
    Traded Dec 3, 2025 Filed Dec 4, 2025
    ↗
11. James P Mackin CEO
    Planned sale
    $1.4M 30,921 shares at $45.56 3.7% of stake
    Traded Dec 2, 2025 Filed Dec 3, 2025
    ↗
12. Marshall S. Stanton SVP, Clinical & MD Affair
    Sale
    $2.1M 47,376 shares at $45.04 51% of stake
    Traded Nov 21, 2025 Filed Nov 24, 2025
    ↗
13. Marshall S. Stanton SVP, Clinical & MD Affair
    Sale
    $675K 15,276 shares at $44.18 25% of stake
    Traded Nov 20, 2025 Filed Nov 24, 2025
    ↗
14. Elizabeth A Hoff Director
    Sale
    $189K 4,200 shares at $45.10 13% of stake
    Traded Nov 18, 2025 Filed Nov 19, 2025
    ↗
15. Jean F Holloway SVP, General Counsel
    Planned sale
    $577K 12,787 shares at $45.09 7.3% of stake
    Traded Nov 14–17 Filed Nov 18, 2025
    ↗
16. John E Davis Chief Commercial Officer
    Planned sale
    $574K 12,787 shares at $44.92 6% of stake
    Traded Nov 14–17 Filed Nov 18, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 37 sales to cover taxes, 20 stock grants, 13 option exercises, 2 other transactions, and 1 gift.